Anixa receives Canadian patent allowance for ovarian cancer vaccine

Go back to Anixa receives Canadian patent allowance for ovarian cancer vaccine
(NASDAQ: ANIX) Delayed: 2.77 -0.14 (4.81%)
Previous Close $2.91    52 Week High
Open $2.97    52 Week Low
Day High $2.97    P/E N/A 
Day Low $2.75    EPS
Volume 285,078